Matthew J. Meyer
Geen lopende functies
Oorsprong van het eerstegraads netwerk van Matthew J. Meyer
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Cerimon Pharmaceuticals, Inc.
 Cerimon Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology Cerimon Pharmaceuticals, Inc. developed and distributed biopharmaceutical products. It developed Simulect, a monoclonal antibody for the treatment of moderate-to-severe and steroid-refractory ulcerative colitis; diclofenac sodium, a non-steroidal anti-inflammatory drug that are used to treat various pains, included pain due to musculoskeletal injuries and lower back pain; and topical diclofenac sodium patch products. The company was founded by Paul J. Sekhri, Ansbert Gadicke, and Luke Evnin in November 2004 and was headquartered in South San Francisco, CA.
6
| Extinct | Medical Specialties | 6 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Matthew J. Meyer via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| ALZA CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal | |
| LADRX CORPORATION | Biotechnology | Chief Operating Officer | |
| ARIAD PHARMACEUTICALS, INC. | Biotechnology | Founder | |
| GERON CORPORATION | Biotechnology | Corporate Officer/Principal | |
| VERNALIS | Pharmaceuticals: Major | Director/Board Member | |
| DYNAVAX TECHNOLOGIES CORPORATION | Biotechnology | Chief Tech/Sci/R&D Officer | |
| MANNKIND CORPORATION | Pharmaceuticals: Major | Chairman | |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
| ADAMAS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Director/Board Member | |
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Consultant / Advisor | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Doctorate Degree | |
| BIOTIE THERAPIES CORP | Pharmaceuticals: Major | Director/Board Member | |
| AFFYMAX, INC. | Biotechnology | Chief Operating Officer | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
| PACIRA BIOSCIENCES, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| XENON PHARMACEUTICALS INC. | Pharmaceuticals: Major | Director/Board Member | |
Sterling Winthrop, Inc.
 Sterling Winthrop, Inc. Electronics/AppliancesConsumer Durables Part of GSK Plc, Sterling Winthrop, Inc. is a company that specializes in cameras and duplicating machines. The company is based in Rochester, NY. Sterling Winthrop was acquired by GSK Plc from Eastman Kodak Co. on November 03, 1994 for $2,930 million. | Electronics/Appliances | Corporate Officer/Principal | |
| Brandeis University | College/University | Undergraduate Degree | |
| Queen's University of Belfast | College/University | Doctorate Degree | |
| Kenyon College | College/University | Undergraduate Degree | |
| University of Michigan | College/University | Undergraduate Degree | |
| ENDOCYTE, INC. | Pharmaceuticals: Major | Director/Board Member | |
Teikoku Pharma USA, Inc.
 Teikoku Pharma USA, Inc. Pharmaceuticals: MajorHealth Technology Teikoku Pharma USA, Inc. develops and manufactures drugs. It provides patches, unit-dose jellies and liquids, creams, ointments, and other delivery products for pain management and cosmetic care. The company was founded by Masahisa Kitagawa and Ichiro Mori in 1997 and is headquartered in San Jose, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Sandoz Ltd.
 Sandoz Ltd. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Sandoz Ltd. is a British company that develops, produces and markets medicines. The company is based in Camberley, UK and was founded in 1981. | Pharmaceuticals: Major | General Counsel | |
| The Royal College of Physicians | College/University | Corporate Officer/Principal | |
| Sandoz Pharmaceuticals Corp. | Corporate Officer/Principal | ||
Fort Dodge Animal Health, Inc.
 Fort Dodge Animal Health, Inc. Agricultural Commodities/MillingProcess Industries Fort Dodge Animal Health, Inc. manufactures and distributes animal health care products for the livestock, companion animal, equine, and the poultry industries. The company was founded in 1912 and is headquartered in Overland Park, KS. | Agricultural Commodities/Milling | Corporate Officer/Principal | |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| SORRENTO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Immodulon Therapeutics Ltd.
 Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Kyowa Kirin Ltd.
 Kyowa Kirin Ltd. Pharmaceuticals: MajorHealth Technology Founded in 1998, Kyowa Kirin Ltd. is a British pharmaceutical company that develops, manufactures, and distributes pharmaceutical products. Part of Kirin Holdings Co., Ltd., the company is based in London, UK. | Pharmaceuticals: Major | Chairman | |
| Matrix Pharmaceuticals, Inc. | General Counsel | ||
ViiV Healthcare Ltd.
 ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Amgen SF LLC
 Amgen SF LLC Pharmaceuticals: MajorHealth Technology Part of Amgen, Inc., Amgen SF LLC is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Thousand Oaks, CA. | Pharmaceuticals: Major | General Counsel | |
The San Francisco SPCA Hospital
 The San Francisco SPCA Hospital Miscellaneous Commercial ServicesCommercial Services The San Francisco SPCA Hospital provides animal welfare and protection programs. It provides care of animals that are homeless, ill or in need of an advocate also work to educate the community, reduce the number of unwanted kittens and puppies through spaying/neutering, and improve the quality of life for animals and their companions. The company was founded on April 18, 1868 and is headquartered in San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
| Pritzker School of Medicine | College/University | Doctorate Degree | |
| PROQR THERAPEUTICS N.V. | Pharmaceuticals: Major | Chairman | |
Impatients NV
 Impatients NV Miscellaneous Commercial ServicesCommercial Services Impatients N.V. operates an online platform for drug innovations. It provides physicians and patients that are excluded from clinical trials access to drugs in development via early access programs. The company was founded by Ronald Brus, SJaak Vink, Govert J. Schouten, Witt Jan, Erdem Yavuz, and René Beukema in 2012 and is headquartered in Amsterdam, the United Kingdom. | Miscellaneous Commercial Services | Chairman | |
Leyden Laboratories B.V.
 Leyden Laboratories B.V. Miscellaneous Commercial ServicesCommercial Services Leyden Laboratories B.V. is a biotechnology company based in Amsterdam, Netherlands. Leyden Labs aims to protect humanity from known and future viruses by targeting commonalities of viral families. The Dutch company has developed a portfolio of accessible intranasal product candidates that may provide people with the freedom to immediately protect themselves from and prevent the spread of many strains of respiratory viruses, including ones in the influenza and coronavirus families. The company's energetic team of world-renowned biotechnology veterans and fresh talent is dedicated to thinking differently to free humanity from the burden of respiratory viruses. Leyden Labs is backed with $200m by blue-chip investors Casdin Capital, GV (formerly Google Ventures), F-Prime Capital, Byers Capital/Brook Byers, SoftBank Investment Advisers, Invus, and Bluebird Ventures. The company was founded in June 2020 by Koenraad Wiedhaup, Jaap Goudsmit, Domenico Valerio, and Ronald H. P. Brus, with Koenraad Wiedhaup serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 31 |
| Verenigd Koninkrijk | 10 |
| Nederland | 5 |
| Ierland | 3 |
| Canada | 3 |
Sectoraal
| Health Technology | 33 |
| Consumer Services | 8 |
| Commercial Services | 6 |
| Finance | 2 |
| Consumer Durables | 2 |
Operationeel
| Director/Board Member | 61 |
| Corporate Officer/Principal | 26 |
| Independent Dir/Board Member | 16 |
| Chief Tech/Sci/R&D Officer | 16 |
| Chairman | 13 |
Sterkste connecties
| Insiders | |
|---|---|
| Paul Sekhri | 62 |
| James Shannon | 22 |
| Gary Patou | 17 |
| Daniel J. Levitt | 13 |
| Natalie L. McClure | 8 |
| Scott T. Shearer | 7 |
- Beurs
- Insiders
- Matthew J. Meyer
- Bedrijfsconnecties
